GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

ImExHS IME.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.35

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2025

Revenue

A$29.0m

FY2016FY2025

Net income

−A$2.9m

FY2016FY2025

Free cash flow

A$244,160

FY2016FY2025

Shareholders' equity

A$15.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueA$29.0mA$26.6mA$19.7mA$17.1mA$13.4mA$10.9mA$7.7mA$5.8mA$3.5mA$80,117
Research and developmentA$2.3mA$2.9mA$2.4mA$1.5mA$1.1mA$646,665A$2.1mA$1.3mA$19,539A$280,718
Operating income−A$697,638−A$367,112−A$4.0m−A$2.5m−A$4.2m−A$2.3m−A$5.1m−A$4.3m−A$592,000−A$4.0m
Net income−A$2.9m−A$2.6m−A$4.2m−A$3.0m−A$4.7m−A$3.6m−A$6.0m−A$4.9mA$68,469−A$4.5m
Diluted earnings per share-0.05-0.06-0.10-0.08-0.15-0.13-0.31-0.260.01-2.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsA$23.7mA$21.8mA$22.7mA$21.0mA$25.0mA$20.8mA$14.8mA$9.3mA$1.5mA$496,052
Cash and short-term investmentsA$3.3mA$2.1mA$2.4mA$1.9mA$4.2mA$10.8mA$7.1mA$2.4mA$963,959A$187,739
Total liabilitiesA$7.9mA$7.3mA$6.7mA$5.1mA$8.4mA$5.3mA$4.5mA$3.4mA$89,093A$822,152
DebtA$566,323A$1.2mA$1.3mA$1.1mA$2.4mA$1.7mA$2.1mA$188,491A$457,387A$250,000
Shareholders' equityA$15.9mA$14.5mA$16.0mA$15.9mA$16.7mA$15.5mA$10.3mA$5.9mA$1.5m−A$326,100
Shares outstanding54m46m42m40m32m27m20m19m13m2m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsA$564,707−A$634,679A$2.6m−A$2.2m−A$3.0m−A$1.5m−A$4.1m−A$1.5m−A$109,862−A$3.7m
Capital spending−A$320,547−A$1.1m−A$2.2m−A$2.0m−A$2.6m−A$2.2m−A$2.3m−A$1.3m−A$370,487−A$29,706
Free cash flowA$244,160−A$1.7mA$414,592−A$4.2m−A$5.5m−A$3.7m−A$6.4m−A$2.9m−A$480,349−A$3.7m
Dividends paid———−A$2.0m−A$101,888−A$6.9m−A$2.4m———

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueA$15.9mA$15.3mA$13.7mA$12.7mA$13.9mA$10.9mA$8.8mA$7.7m
Operating incomeA$194,575A$151,897−A$84,214A$713,445−A$1.1m−A$1.6mA$426,127−A$935,000
Net incomeA$66,200A$122,407−A$3.0m−A$1.1m−A$1.5m−A$1.9m−A$2.3m−A$1.3m
Diluted earnings per share0.000.00-0.06-0.02-0.03-0.04-0.05-0.03
Cash from operations—A$2.0m−A$1.0m—−A$1.0mA$1.0mA$1.0m—
Capital spending———−A$1.0m—−A$1.0m−A$1.0m—
Free cash flow—————A$0A$0—
Total assetsA$26.6mA$23.7mA$22.8mA$21.8mA$21.8mA$22.7mA$22.9mA$21.0m
Cash and short-term investmentsA$2.0mA$3.3mA$2.5mA$2.1mA$1.9mA$2.4mA$2.0mA$1.9m
DebtA$452,997A$566,322A$1.4mA$1.2mA$951,379A$1.3mA$966,002A$1.1m
Shareholders' equityA$17.2mA$15.9mA$14.4mA$14.5mA$15.1mA$16.0mA$16.7mA$15.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.2%21.6%77.9%
Operating income-35.1%-21.6%-4.2%
Net income-1.7%-4.4%0.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1.9%-8.2%-12.2%-21.8%
Net margin-9.9%-13.8%-18.1%-29.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-7.5-6.5-6.8-6.1-7.0-12.1-6.2-4.8287.1-31.6
Price to sales0.80.61.41.12.54.04.84.15.5—

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 50-to-1 reverse split · 4 Nov 2020
  • 10-to-1 reverse split · 2 Jun 2017
  • 1-to-1 reverse split · 2 Jun 2015
  • 3-to-1 reverse split · 21 Apr 2011
  • 10-to-1 reverse split · 31 Mar 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.